Concurrent Technologies Plc (CNC)
London Exchange · UK · prices in GBX · close of 21 Oct 2026
Key indicators
| Last close | GBX 268.00 |
|---|---|
| 52-week range | 172.74 – 286.00 |
| Return, 1 month / 3 months | +7.2% / −2.5% |
| Return, 1 year / 3 years | +17.5% / +320.5% |
| Trend | Uptrend |
| RSI (14) | 55 |
| Volatility (1 year) | 39.2% |
| Worst drawdown (1 year) | -33.0% |
| Average daily value traded | 51.78M GBX |
| Dividend yield | 0.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Concurrent Technologies designs and makes embedded computer hardware, chiefly processor boards and systems built around commercial microprocessors. Its products are used in demanding environments by customers in defence, aerospace, telecommunications, transport and industrial markets, where reliable computing in compact or rugged formats matters. The company is based in Colchester in the United Kingdom and supplies both standard products and customised designs to equipment makers and systems integrators.
The shares are listed on the London Exchange in UK under the code CNC, and the price on this page is in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Concurrent Technologies Plc (CNC) trades on the London Exchange in UK. It last closed at GBX 268.00 on 21 October 2026.
Its price-based Market X-Ray is 56 out of 100 (a fair price profile), ranking 1,661 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 17.5% and over the last three months it fell 2.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 71 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 8.2% | ||
| From 52-week high | -4.3% | ||
| Momentum | 58 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -2.5% | ||
| 6-month return | 13.3% | ||
| 12-month return, skipping the last month | 9.7% | ||
| Stability (higher is calmer) | 42 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 39.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -33.0% | ||
| Liquidity | 85 · Strong | Trades actively. | |
| Average daily value traded | 51.78M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 5 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.0% | ||
| Years with dividends | 4 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +2.1% |
|---|---|
| 1 month | +7.2% |
| 3 months | −2.5% |
| 6 months | +13.3% |
| 1 year | +17.5% |
| 3 years | +320.5% |
| 5 years | +231.3% |
Signals
| 50-day / 200-day average | 256.23 / 247.60 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 11.75 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 18 Jun 2026 | GBP 0.0116 |
| 19 Jun 2025 | GBP 0.0110 |
| 27 Jun 2024 | GBP 0.0100 |
| 7 Jul 2022 | GBP 0.0140 |
| 16 Sep 2021 | GBP 0.0115 |
| 18 Mar 2021 | GBP 0.0145 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.